Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C

Ann Otol Rhinol Laryngol. 2001 Nov;110(11):1007-10. doi: 10.1177/000348940111001103.

Abstract

To develop a model for recurrent anterior glottic stenosis and to test the efficacy of topical mitomycin-C in preventing restenosis, we induced anterior glottic stenosis with a CO2 laser in 5 dogs. In 3 dogs, recurrence was established after surgical lysis. Subsequently, the 3 dogs received a single topical 3-minute treatment with a 1% solution of mitomycin-C after a second surgical lysis. In a parallel experiment, the other 2 dogs received a single topical 3-minute treatment with a 1% solution of mitomycin-C after the initial surgical lysis. An anterior glottic web was induced in all 5 dogs with the CO2 laser. The 3 dogs experienced restenosis at the anterior glottis after surgical lysis alone. Mitomycin-C prevented anterior glottic restenosis in 2 of the 3 dogs treated twice and in both of the dogs treated once (p = .02). We conclude that a recurrent stenosis of the anterior glottis may be induced reproducibly in the canine model with the CO2 laser. Application of topical mitomycin-C after lysis of an anterior glottic stenosis produces a statistically significant reduction in the rate of restenosis as compared to surgical lysis alone.

MeSH terms

  • Administration, Topical
  • Animals
  • Antibiotics, Antineoplastic / therapeutic use*
  • Disease Models, Animal
  • Dogs
  • Glottis*
  • Laryngostenosis / prevention & control*
  • Laryngostenosis / surgery
  • Mitomycin / therapeutic use*
  • Postoperative Complications / prevention & control*
  • Recurrence

Substances

  • Antibiotics, Antineoplastic
  • Mitomycin